Literature DB >> 19706904

Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico.

Lucio Galavíz-Silva1, Daniel P Molina-Garza, Mario A González-Santos, Roberto Mercado-Hernández, José Reyes González-Galavíz, José Luis Rosales-Encina, Zinnia J Molina-Garza.   

Abstract

Chagas disease has become frequent in non-endemic areas, where it can be transmitted by blood transmission. Therefore, we explored seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors at the Cardiology Hospital, Mexican Institute of Social Security at Monterrey, Nuevo León, by both an enzyme-linked immunosorbent assay and indirect hemagglutination. Blood samples from 1,000 healthy blood donors were selected. A seropositivity of 2.8% was shown among the studied population, of which 2.59% (21/809) were inhabitants of Nuevo León, whereas 3.07% (2/65) and 3.96% (5/126) were from Coahuila and Tamaulipas, respectively. Our result is higher than that of a previous study from 1998, where a prevalence of 0.5% was reported. This once again corroborates the importance of installing a surveillance program to detect and prevent the transfusion of T. cruzi from asymptomatic blood donors in blood banks located in urban cities recognized as non-endemic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706904

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  A Critical Assessment of Officially Reported Chagas Disease Surveillance Data in Mexico.

Authors:  Ellen M Shelly; Rodolfo Acuna-Soto; Kacey C Ernst; Charles R Sterling; Heidi E Brown
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

2.  Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole.

Authors:  Ignacio Martínez; Benjamín Nogueda; Fernando Martínez-Hernández; Bertha Espinoza
Journal:  Vector Borne Zoonotic Dis       Date:  2013-02-19       Impact factor: 2.133

Review 3.  A global systematic review of Chagas disease prevalence among migrants.

Authors:  Erin E Conners; Joseph M Vinetz; John R Weeks; Kimberly C Brouwer
Journal:  Acta Trop       Date:  2016-01-08       Impact factor: 3.112

4.  Trypanosoma cruzi: seroprevalence detection in suburban population of Santiago de Querétaro (Mexico).

Authors:  Ángeles López-Céspedes; Elena Villagrán; Kervin Briceño Álvarez; José Antonio de Diego; Hebert Luís Hernández-Montiel; Carlos Saldaña; Manuel Sānchez-Moreno; Clotilde Marín
Journal:  ScientificWorldJournal       Date:  2012-05-03

5.  Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas.

Authors:  Roberto Arena; Christine E Mathews; Anne Y Kim; Tim E Lenz; Paul M Southern
Journal:  BMC Res Notes       Date:  2011-04-29

6.  Association of Trypanosoma cruzi infection with risk factors and electrocardiographic abnormalities in northeast Mexico.

Authors:  Zinnia Judith Molina-Garza; José Luis Rosales-Encina; Roberto Mercado-Hernández; Daniel P Molina-Garza; Ricardo Gomez-Flores; Lucio Galaviz-Silva
Journal:  BMC Infect Dis       Date:  2014-03-01       Impact factor: 3.090

7.  Seroprevalence of T. cruzi infection in blood donors and Chagas cardiomyopathy in patients from the coal mining region of Coahuila, Mexico.

Authors:  José Gerardo Martínez-Tovar; Eduardo A Rebollar-Téllez; Ildefonso Fernández Salas
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Mar-Apr       Impact factor: 1.846

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.